SCHEMBL3169692

SCHEMBL3169692

COc1ccc(N2CCN(CC(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.47
▸ KMT2A Q03164 1/20 0.46
▸ NTSR1 P30989 1/20 0.46
▸ USP2 O75604 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ MTNR1A P48039 1/20 0.43
▸ MTNR1B P49286 1/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175833 0.92 DRD4 (0.51) KMT2AUSP2TSHRLMNASMN1; SMN2
SCHEMBL3165286 0.89 USP2 (0.57) ADORA3KMT2AUSP2TSHRLMNA
SCHEMBL3156668 0.88 MAPT (0.59) KMT2AUSP2TSHRLMNASMN1; SMN2
SCHEMBL3177170 0.88 NTSR1 (0.46) ADORA3KMT2ANTSR1TSHRSMN1; SMN2
SCHEMBL3162796 0.85 ADORA3 (0.53) ADORA3KMT2AUSP2TSHRSMN1; SMN2
SCHEMBL3175773 0.84 GAA (0.55) KMT2ALMNASMN1; SMN2MAPTHTT
SCHEMBL3156070 0.84 TSHR (0.54) ADORA3KMT2AUSP2TSHRLMNA
SCHEMBL3162425 0.84 EGFR (0.53) KMT2AUSP2TSHRLMNASMN1; SMN2
SCHEMBL3163835 0.84 MEN1 (0.46) ADORA3KMT2AUSP2LMNAHTT
SCHEMBL3162900 0.84 MAPT (0.44) KMT2ATSHRLMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback